Alpine Global Management’s MediciNova MNOV Stock Holding History

Alpine Global Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14,467	Closed	-$98K	–	365
2019 Q4	$98K	Buy	+14,467	New	+$109K	0.02%	357

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Alpine Global Management's MNOV Position: Q1 2020 in Review

Alpine Global Management sold out of MediciNova (MNOV) in Q1 2020, closing a stake of 14,467 shares — an estimated $98K sold.

Alpine Global Management first reported a position in MNOV in Q4 2019 and held it in 1 quarter. The position peaked at $98K in Q4 2019. 48 funds tracked by Wall St. Rank hold MNOV as of Q1 2020.

Alpine Global Management reported no remaining MediciNova position as of Q1 2020 after selling out during the quarter.
Alpine Global Management sold 14,467 MediciNova shares in Q1 2020, an estimated $98K.
Alpine Global Management first reported a position in MediciNova in Q4 2019 and held it in 1 quarter.
Alpine Global Management's MediciNova position peaked at $98K in Q4 2019.
48 funds tracked by Wall St. Rank held MediciNova as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.